CYCN

Cyclerion Therapeutics, Inc. Common Stock

1.70

USD

CYCN Earnings Reports

Positive Surprise Ratio

CYCN beat 6 of 13 last estimates.

46%

Next Report

Date of Next Report

Mar 02, 2026

Estimate for Q4 25 (Revenue/ EPS)

Implied change from Q3 25 (Revenue/ EPS)

Implied change from Q4 24 (Revenue/ EPS)

Cyclerion Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, CYCN reported earnings of -0.30 USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached 880.00 thousand, compared to an expected --, with a --% difference. The market reacted with a +1.41% price change (close before vs. close after earnings).

Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

FAQ

What were Cyclerion Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Cyclerion Therapeutics, Inc. Common Stock reported EPS of -$0.30, missing estimates by --, and revenue of $880.00K, -- -- expectations.

How did the market react to Cyclerion Therapeutics, Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 1.41%, changed from $1.42 before the earnings release to $1.44 the day after.

When is Cyclerion Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 02, 2026.

What are the forecasts for Cyclerion Therapeutics, Inc. Common Stock's next earnings report?

Based on -- analysts, Cyclerion Therapeutics, Inc. Common Stock is expected to report EPS of -- and revenue of -- for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.